X-linked adrenoleukodystrophy: Diagnostic and follow-up system in Japan
Open Access
- 11 November 2010
- journal article
- review article
- Published by Springer Nature in Journal of Human Genetics
- Vol. 56 (2) , 106-109
Abstract
X-linked adrenoleukodystrophy (ALD) is an intractable neurodegenerative disease associated with the accumulation of very long-chain saturated fatty acids (VLCFA) in tissues and body fluids. We have established a Japanese referral center for the diagnosis of ALD, using VLCFA measurements and mutation analysis of the ABCD1 gene, and have identified 60 kinds of mutations in 69 Japanese ALD families, which included 38 missense mutations, 6 nonsense mutations, 8 frame-shift mutations, 3 amino acid deletions, 2 exon-skip mutations and 3 large deletions. A total of 24 kinds of mutations (40%) were identified only in Japanese patients by referring to the current worldwide ALD mutation database. There was no clear correlation between these mutations and phenotypes of 81 male patients in these 69 families. About 12% of the individuals with ALD had de novo mutations by mutation analysis in the male probands and their mothers, which should be helpful data for genetic counseling. The only effective therapy for the cerebral form of ALD should be hematopoietic stem cell transplantation at the early stages of the cerebral symptoms, therefore, we performed presymptomatic diagnosis of ALD by extended familial screening of the probands with careful genetic counseling, and established a long follow-up system for these patients to prevent the progression of brain involvement and to monitor the adrenocortical insufficiency. Further elucidation of pathology in ALD, especially concerning the mechanisms of the onset of brain involvement, is expected.Keywords
This publication has 10 references indexed in Scilit:
- Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked AdrenoleukodystrophyScience, 2009
- Newborn screening for X-linked adrenoleukodystrophy (X-ALD): Validation of a combined liquid chromatography–tandem mass spectrometric (LC–MS/MS) methodMolecular Genetics and Metabolism, 2009
- Natural history of X-linked adrenoleukodystrophy in JapanBrain and Development, 2005
- Follow-up of 89 Asymptomatic Patients With Adrenoleukodystrophy Treated With Lorenzo’s OilArchives of Neurology, 2005
- Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screeningThe Journal of Pediatrics, 2005
- Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999Blood, 2004
- Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disordersBrain and Development, 2003
- Epidemiology of X-linked adrenoleukodystrophy in JapanJournal of Human Genetics, 2002
- Accurate DNA-Based Diagnostic and Carrier Testing for X-Linked AdrenoleukodystrophyMolecular Genetics and Metabolism, 1999
- Plasma very long chain fatty acids in 3,000 peroxisome disease patients and 29,000 controlsAnnals of Neurology, 1999